URI
43
-2
CVS
29
-7
MU
35
-7
R
70
3
FOX
60
7
NOC
45
2
BLK
60
-3
PYPL
60
-2
EA
52
-2
AAP
32
-3
VRSK
66
3
FRT
43
5
LEN
42
-4
CTSH
52
-4
PDCO
77
2
CCL
70
-2
TRV
40
-2
DE
53
-3
STI
21
-3
NKE
40
-2
URI
43
-2
CVS
29
-7
MU
35
-7
R
70
3
FOX
60
7
NOC
45
2
BLK
60
-3
PYPL
60
-2
EA
52
-2
AAP
32
-3
VRSK
66
3
FRT
43
5
LEN
42
-4
CTSH
52
-4
PDCO
77
2
CCL
70
-2
TRV
40
-2
DE
53
-3
STI
21
-3
NKE
40
-2
Financhill
Back

Biotest AG Quote, Financials, Valuation and Earnings

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Sell
11

BTTAY
Biotest AG

Last Price:
24.27
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Biotest AG Price Quote

$24.27

Biotest AG Key Stats

Sell
11
Biotest AG (BTTAY) is a Sell
Day range:
$24.27 - $24.27
52-week range:
$24.27 - $24.27
Dividend yield:
0%
P/E ratio:
14.01
P/S ratio:
2.49
P/B ratio:
3.26%
Volume:
0
Avg. volume:
0
1-year change:
0%
Market cap:
$1.9B
Revenue:
$741.2M
EPS:
$0.92

How Much Does Biotest AG Make?

Is Biotest AG Growing As A Company?

  • What Is Biotest AG's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.32%
  • What Is Biotest AG's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Biotest AG Stock Price Performance

  • Did Biotest AG Stock Go Up Last Month?
    Biotest AG share price went up by 0% last month
  • Did BTTAY's Share Price Rise Over The Last Year?
    BTTAY share price rose by 0% over the past 1 year

What Is Biotest AG 52-Week High & Low?

  • What Is Biotest AG’s 52-Week High Share Price?
    Biotest AG has traded as high as $24.27 over the past 52 weeks
  • What Is Biotest AG’s 52-Week Low Share Price?
    Biotest AG has traded as low as $24.27 over the past 52 weeks

Biotest AG Price To Free Cash Flow

Is It Risky To Buy Biotest AG?

  • How Much Debt Does Biotest AG Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Biotest AG Have?
    Cash and short term investments quarterly total is $42.2M
  • What Is Biotest AG’s Book Value Per Share?
    Book value per share is 7.44

Is Biotest AG Cash Flow Positive?

  • What Is BTTAY Cash Flow From Operations?
    Cash flow from operations (TTM) is $97.9M
  • What Is Biotest AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$106.6M
  • What Is Biotest AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$36.6M

Biotest AG Return On Invested Capital

  • Is Management Doing A Good Job?
    BTTAY return on invested capital is 10.9%
  • What Is Biotest AG Return On Assets?
    ROA measures how assets are converting to revenues and is 4.9%
  • What Is BTTAY Return On Equity?
    ROE is a measure of profitability and is 13.32%

Biotest AG Earnings Date & Stock Price

  • What Is Biotest AG's Stock Price Today?
    A single share of BTTAY can be purchased today for 24.27
  • What Is Biotest AG’s Stock Symbol?
    Biotest AG trades on the otcm under the ticker symbol: BTTAY
  • When Is Biotest AG’s Next Earnings Date?
    The next quarterly earnings date for Biotest AG is scheduled on December 13, 2024
  • When Is BTTAY's next ex-dividend date?
    Biotest AG's next ex-dividend date is December 13, 2024
  • How To Buy Biotest AG Stock?
    You can buy Biotest AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biotest AG Competitors

  • Who Are Biotest AG's Competitors?
    Below is a list of companies who compete with Biotest AG or are related in some way:

Biotest AG Dividend Yield

  • What Is BTTAY Dividend Yield?
    Biotest AG’s dividend yield currently is 0%
  • What Is Biotest AG’s Payout Ratio?
    Biotest AG’s payout ratio is 0%
  • When Did Biotest AG Last Pay A Dividend?
    The latest dividend pay date is December 13, 2024
  • What Is Biotest AG’s Dividend Per Share?
    Biotest AG pays a dividend of $0.00 per share

Biotest AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -32.34% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable